Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients

Eur J Haematol. 2024 May;112(5):840-844. doi: 10.1111/ejh.14177. Epub 2024 Feb 2.

Abstract

Introduction: Early death (ED) is the unsolved issue of acute promyelocytic leukemia (APL). The disseminated intravascular coagulation (DIC) score has been proposed as a marker of bleeding and death in APL; whether its temporal evolution predicts outcomes in APL is unknown. We evaluated whether an increasing score 48 h after diagnosis associates with ED.

Methods: Retrospective, single-center study, including patients with newly diagnosed APL between 2000 and 2023, treated with all-transretinoic acid (ATRA) plus anthracycline or arsenic trioxide (ATO). "DIC score worsening" was defined as ≥1 point increase in the score after 48 h, and ED as death within 30 days of diagnosis.

Results: Eighty-six patients were included, with median age of 46 years (17-82). ED patients (26.7%) more frequently had age >60 years and worsening DIC score after 48 h. These were also the only predictors of ED identified in both univariate and multivariate (OR 4.18, p = .011; OR 7.8, p = .005, respectively) logistic regression analysis.

Conclusion: This is the first study on DIC score evolution in APL-a worsening DIC score 48 h after diagnosis is a strong independent predictive factor of ED. We propose a reduction of the DIC score from diagnosis as a new treatment goal in APL care.

Keywords: acute promyelocytic leukemia; coagulopathy; disseminated intravascular coagulation; disseminated intravascular coagulation score; early death.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Arsenic Trioxide / adverse effects
  • Disseminated Intravascular Coagulation* / complications
  • Disseminated Intravascular Coagulation* / etiology
  • Humans
  • Leukemia, Promyelocytic, Acute* / complications
  • Leukemia, Promyelocytic, Acute* / diagnosis
  • Leukemia, Promyelocytic, Acute* / drug therapy
  • Middle Aged
  • Retrospective Studies
  • Tretinoin / therapeutic use
  • Young Adult

Substances

  • Tretinoin
  • Arsenic Trioxide